8-K: FONAR Reports Mixed Fiscal 2025 Results Amid Profit Decline

FONAR Corporation announced its Fiscal 2025 financial results, showing a 1% revenue increase but significant declines in operating and net income, alongside continued growth in scan volume.

Summary

• Total Revenues Net increased by 1% to $104.4 million for the fiscal year ended June 30, 2025, compared to $102.9 million in the prior fiscal year.
• Income from Operations decreased by 30% to $11.6 million for Fiscal 2025, down from $16.5 million in the previous fiscal year.
• Net Income decreased by 24% to $10.7 million for Fiscal 2025, compared to $14.1 million in the prior fiscal year.
• Diluted Net Income per Common Share decreased by 20% to $1.23 for Fiscal 2025, down from $1.53 in the previous fiscal year.
• Total Costs and Expenses increased by 7% to $92.8 million for Fiscal 2025, up from $86.3 million in the prior fiscal year.
• Selling, General and Administrative (SG&A) expenses increased by 11% to $29.7 million, largely due to a $2.3 million reserve related to a New York-based motor vehicle insurer.
• HMCA, the diagnostic imaging management subsidiary, achieved a record 216,317 scans in Fiscal 2025, a 3.3% increase from 209,346 scans in Fiscal 2024.
• Working Capital increased by 4% to $127.5 million, and Book Value per Share increased to $25.26 per share for Fiscal 2025.
• The company added two HMCA-managed MRI scanners in Fiscal 2025, bringing the total to 44, with new high-field MRIs installed in Naples, FL, and Melville, NY.

Sentiment

Score: 4

Explanation: The sentiment is mixed, leaning negative due to significant declines in operating and net income and diluted EPS, despite modest revenue growth and operational expansion. A new risk factor related to an insurer reserve also weighs on the results. The potential 'Take Private' transaction introduces uncertainty but could be a positive for shareholders.

Positives

• Total Revenues Net increased by 1% to $104.4 million for Fiscal 2025.
• Diagnostic imaging center segment revenue increased by 1% to $95.4 million.
• Product Sales and Upgrades and Service and Repair Fees increased to $9.0 million from $8.3 million.
• HMCA's scan volume reached a record 216,317 in Fiscal 2025, a 3.3% increase year-over-year.
• New York region scan volume grew by 4.4% to 133,663 scans.
• Working Capital increased by 4% to $127.5 million for Fiscal 2025.
• Book Value per Share increased to $25.26 per share for Fiscal 2025.
• Total Assets increased to $216.9 million, while Total Liabilities decreased to $56.8 million.
• The Current Ratio improved to 8.4 at June 30, 2025.
• Research and Development expenses decreased by 9% to $1.6 million.
• Two new HMCA-managed MRI scanners were added, bringing the total to 44.

Negatives

• Income from Operations decreased by 30% to $11.6 million for Fiscal 2025.
• Net Income decreased by 24% to $10.7 million for Fiscal 2025.
• Diluted Net Income per Common Share decreased by 20% to $1.23 for Fiscal 2025.
• Total Costs and Expenses increased by 7% to $92.8 million.
• Selling, General and Administrative (SG&A) expenses increased by 11% to $29.7 million, primarily due to a $2.3 million reserve.
• Operating Cash Flow decreased to $11.3 million for Fiscal 2025 from $14.1 million in the prior year.
• Florida scan volume growth was slower at 1.6%, partially attributed to tort reform.

Risks

• Tort reform in Florida is impacting MRI providers by changing how medical expenses are valued in personal injury cases, limiting recovery amounts, and resulting in fewer patients seeking MRI services and reduced payments.
• The company has a $2.3 million reserve due to risk exposure related to a New York-based motor vehicle insurer focused on for-hire automotive insurance, which reported a $650 million shortfall at the end of 2024.

Future Outlook

The company plans to install a high-field MRI in a Stand-Up MRI facility in Nassau County, Long Island, expected to be operational in the first half of Fiscal 2026. An additional HMCA-managed center is also planned for Nassau County later in Fiscal 2026. The company continues to seek locations to expand its New York and Florida networks with Stand-Up MRI technology and is carefully monitoring the situation with the New York-based motor vehicle insurer.

Management Comments

• "I am pleased to report that our diagnostic imaging management subsidiary, Health Management Company of America (HMCA), the Company’s primary source of revenue and profit, continues to grow."
• "Scan volume at HMCA-managed sites has increased every fiscal year since COVID in Fiscal 2020. We reached a record of 216,317 scans in Fiscal 2025, which was 3.3% higher than the previous record of 209,346 in Fiscal 2024."
• "Florida growth is partially due to tort reform in Florida, which impacts MRI providers by changing how medical expenses are valued in personal injury cases. It also limits the amount that can be recovered in court for medical bills, affecting MRI providers use of Letters of Protection. Overall, the bill has resulted in fewer patients seeking MRI services and reduced payments to providers."
• "A high-field MRI is a perfect complement to the Stand-Up MRI. The Stand-Up MRI is the most non-claustrophobic, patient-friendly MRI; it’s the only MRI that can scan patients in weight-bearing positions, which enables the detection of pathology that could be underestimated or missed entirely on conventional lie-down-only MRIs."
• "At the moment we’re installing a high-field MRI in a Stand-Up MRI facility in Nassau County, Long Island, which we expect will be operational in the first half of Fiscal 2026. We’re also planning for an additional HMCA-managed center in Nassau County later in the fiscal year."
• "Selling, general, and administration expenses increased by $2.9 million, or 10.7%, from $26.9 million in Fiscal 2024 to $29.7 million in Fiscal 2025. This was largely due to the need for the Company to take an additional $2.3 million reserve resulting from our risk exposure related to a New York-based motor vehicle insurer focused on for-hire automotive insurance, such as the taxi industry."
• "Due to the potential Take Private transaction that was announced on July 18, 2025, which may result in the Company acquiring all of the capital stock held by our public shareholders, we have temporarily suspended share repurchases until further notice."
• "I remain grateful for our management team and all the FONAR and HCMA employees whose hard work and commitment continue to make the Company successful."

Industry Context

The diagnostic imaging industry, particularly MRI services, continues to see demand, as evidenced by FONAR's increasing scan volumes. However, regional regulatory changes, such as tort reform in Florida, can significantly impact provider revenues and patient access. The integration of high-field MRIs with specialized Stand-Up MRI technology reflects a trend towards offering more versatile and patient-friendly imaging solutions to meet diverse diagnostic needs. The mention of a 'Take Private' transaction suggests potential consolidation or strategic shifts within the medical technology sector, possibly driven by market valuations or a desire for greater operational control.

Related Party Transactions

• Management and other fees from related medical practices: $12,293,968 (2025) vs $11,949,900 (2024).
• Service and repair fees from related parties: $180,000 (2025) vs $139,167 (2024).
• Costs related to service and repair fees related parties: $323,504 (2025) vs $144,413 (2024).
• Costs related to management and other fees related medical practices: $6,388,281 (2025) vs $6,143,728 (2024).
• Interest income from related party: $51,917 (2025) vs $25,959 (2024).
• Note receivable related party: $554,857 (2025) vs $581,183 (2024).
• Prepaid expenses and other current assets related party: $410,659 (2025) vs $0 (2024).
• Due to related party medical practices: $92,663 (2025) vs $92,663 (2024).

Stakeholder Impact

• Shareholders: Experienced a 20% decrease in diluted net income per common share. The stock repurchase plan is temporarily suspended due to a potential 'Take Private' transaction, which could offer a premium for public shareholders.
• Employees: Management expressed gratitude for their hard work and commitment, indicating continued operational stability.
• Customers (patients): Benefit from the addition of new high-field MRI scanners and the unique capabilities of Stand-Up MRI technology, offering more diagnostic options and patient comfort.
• Medical Practices (HMCA-managed): Continued growth in scan volume and expansion of managed centers indicate ongoing business for these practices.
• Creditors: The company maintains a strong current ratio of 8.4 and a healthy total assets/total liabilities ratio of 3.8, suggesting good financial health for meeting obligations.

Next Steps

• Install a high-field MRI in a Stand-Up MRI facility in Nassau County, Long Island, expected to be operational in the first half of Fiscal 2026.
• Plan for an additional HMCA-managed center in Nassau County later in Fiscal 2026.
• Continue to search for locations where Stand-Up MRI technology can profitably enhance existing New York and Florida networks.
• Carefully monitor the situation regarding the New York-based motor vehicle insurer and its $650 million shortfall.

Key Dates

Recommendation

The company reported mixed Fiscal 2025 results, with modest revenue growth offset by significant declines in operating and net income, and diluted EPS. This profitability erosion is partly due to increased SG&A expenses, including a substantial reserve for a specific insurer risk. While operational growth in scan volume and expansion of MRI facilities are positive, the financial performance is concerning. The temporary suspension of share repurchases due to a potential 'Take Private' transaction introduces a speculative element; if completed at a premium, it could benefit current shareholders. However, without further details on the 'Take Private' offer or resolution of the insurer risk, a 'hold' recommendation is prudent, advising investors to await more clarity on these significant developments before making further investment decisions.

Keywords

FONAR, HMCA, MRI, diagnostic imaging, financial results, fiscal 2025, earnings, healthcare, medical devices, Stand-Up MRI, tort reform, New York, Florida, profitability, revenue